摘要
Abstract
OBJECTIVE:To discuss effects of Bifid triple viable capsules combined with Dahuang chishao decoction on endo-toxemia and intestinal mucosal barrier function of patients with hepatocirrhosis. METHODS:90 patients with hepatocirrhosis were randomly divided into traditional Chinese and western medicine group and western medicine group with 45 cases in each group. Both groups were given symptomatic treatment,such as liver protection and diuresis,lowering portal pressure and nutrition sup-port. Based on this,western medicine group was given Bifid triple viable capsules 0.42 g,tid,po;traditional Chinese and western medicine group was additionally given Dahuang chishao decoction orally,one dose a day,on the basis of western medicine group. Both 2 groups were treated for 6 weeks. The changes of liver function index,serum endotoxin(ET),procalcitonin(PCT)and di-amine oxidase (DAO) levels of patients were observed and recorded in 2 groups before and after treatment. RESULTS:After 6 weeks treatment,serum ALT,AST and TBIL,ET,PCT and DAO levels of patients in 2 groups declined significantly,compared with before treatment,with statistical significance(P<0.05 or P<0.01);the decrease of traditional Chinese and western medicine group was more significant than western medicine group,with statistical significance(P<0.05). CONCLUSIONS:Bifid triple via-ble capsules combined with Dahuang chishao decoction can reduce ALT,AST and TBIL levels in patients with hepatocirrhosis,pro-tect liver function;reduce serum ET,PCT and DAO levels,release endotoxemia,and protect and remedy intestinal mucosal barri-er function.关键词
肝硬化/双歧杆菌三联活菌胶囊/大黄赤芍汤/内毒素血症/肠黏膜屏障功能Key words
Hepatocirrhosis/Bifid triple viable capsules/Dahuang chishao decoction/Endotoxemia/Intestinal mucosal barrier function分类
医药卫生
